OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
George is the cofounder and managing director of Sixfold Bioscience, a Y Combinator backed biotech that utilises advanced nanoengineering to create safer and more targeted systems for the delivery of RNA therapies. Sixfold’s Mergo™ platform has been designed from the bottom-up to overcome some major limitations of traditional drug delivery systems and unlock treatments for potentially thousands of diseases. Prior to Sixfold, George completed his PhD at Cambridge University where he implemented novel methods for the visualisation of nano-structures in complex cellular models. In this talk George will present a short overview of his career, life at a startup, how to attract funding and building a multidisciplinary team from scratch.
